Parul Tandon
University of Toronto
Internal medicineObstetricsOdds ratioIntensive care medicineProspective cohort studyColitisUpper gastrointestinal bleedingCongenital cytomegalovirus infectionGastrointestinal bleedingInflammatory bowel diseaseCalprotectinDiseasePregnancyDiarrheaUlcerative colitisIn patientIncidence (epidemiology)MedicineParenteral nutritionGastroenterologyMeta-analysis
63Publications
12H-index
420Citations
Publications 64
Newest
#1Gurpreet Malhi (UWO: University of Western Ontario)H-Index: 1
#2Parul Tandon (U of T: University of Toronto)H-Index: 12
Last. Vivian Huang (U of T: University of Toronto)H-Index: 19
view all 5 authors...
Background null Women with inflammatory bowel disease (IBD) have an increased risk of postpartum disease activity. We aimed to systematically determine the effect of various risk factors on postpartum IBD disease activity. null Methods null Electronic databases were searched through January 2021 for studies that reported risk of postpartum disease activity in women with IBD. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated for the impact of IBD phenotype, disease acti...
Source
#1Parul Tandon (U of T: University of Toronto)H-Index: 12
#2Vivek Govardhanam (U of T: University of Toronto)H-Index: 2
Last. Adam V. Weizman (U of T: University of Toronto)H-Index: 17
view all 4 authors...
Source
#1Conor Bell (McMaster University)H-Index: 1
#2Parul Tandon (U of T: University of Toronto)H-Index: 12
Last. Neeraj Narula (McMaster University)H-Index: 23
view all 5 authors...
BACKGROUND AND AIM Vedolizumab is a novel monoclonal antibody used in patients with inflammatory bowel disease, often affecting women of child-bearing age. We aimed to compare maternal and fetal adverse outcomes in pregnancies of women with inflammatory bowel disease exposed to vedolizumab versus those on other treatment. METHODS We performed a systematic literature search through December 2020 looking for studies including outcomes from pregnancies of female inflammatory bowel disease patients ...
Source
#1Daljeet ChahalH-Index: 5
#2Hasrit Sidhu (UBC: University of British Columbia)
Last. Fergal DonnellanH-Index: 13
view all 7 authors...
BACKGROUND Hemospray (TC-325) is now approved for use in gastrointestinal bleeding. Data regarding their use pattern, efficacy, complications, and impact on clinical outcomes is limited. METHODS Electronic search from relevant databases was conducted up to January 2019. Etiologies, therapy characteristics, hemostasis rates, rebleed rates, additional procedures, complications and mortality rates were extracted and pooled. RESULTS Twenty-seven articles were included for analysis (n=1916). Pooled h...
Source
#1Rishad Khan (U of T: University of Toronto)H-Index: 12
#2Parul Tandon (U of T: University of Toronto)H-Index: 12
Last. Samir C. GroverH-Index: 15
view all 20 authors...
Background The coronavirus disease 2019 (COVID-19) pandemic has impacted endoscopy services and education worldwide. This study aimed to characterize the impact of COVID-19 on gastroenterology trainees in Canada. Methods An analysis of Canadian respondents from the international EndoTrain survey, open from April 11 to May 2 2020 and distributed by program directors, trainees, and national and international gastroenterology societies' representatives, was completed. The survey included questions ...
1 CitationsSource
#1Rohit Jogendran (U of T: University of Toronto)
#2Parul Tandon (U of T: University of Toronto)H-Index: 12
Last. Vivian Huang (U of T: University of Toronto)H-Index: 19
view all 5 authors...
BACKGROUND AND AIMS Factors affecting pregnancy-related knowledge in women with inflammatory bowel disease (IBD) remain unknown. We aimed to determine these factors and to assess the impact of a dedicated pregnancy clinic on improving knowledge in women with IBD. METHODS Adult women with IBD attending the pregnancy IBD clinic at the University of Alberta from 2014 to 2018 were enrolled. Each patient completed the Crohn's and Colitis Pregnancy Knowledge (CCPKnow) questionnaire at baseline and aft...
Source
#1Parul Tandon (U of T: University of Toronto)H-Index: 12
#2Eugenia Y Lee (U of T: University of Toronto)H-Index: 1
Last. Vivian M Huang (U of T: University of Toronto)H-Index: 1
view all 9 authors...
BACKGROUND The role of fecal calprotectin in predicting pregnancy-related outcomes in inflammatory bowel disease (IBD) remains unknown. AIM To determine whether increased fecal calprotectin during pregnancy is associated with adverse pregnancy outcomes in IBD. METHODS This is a multicenter cohort study of women with IBD who underwent fecal calprotectin monitoring during pregnancy. Fecal calprotectin levels were stratified by trimester, and adverse pregnancy-related outcomes were recorded. The Ma...
3 CitationsSource
#1Grace WangH-Index: 13
Last. Vivian HuangH-Index: 19
view all 7 authors...
Source
#1Parul Tandon (U of T: University of Toronto)H-Index: 12
#2Neeraj Narula (McMaster University)H-Index: 23
Source
#1Kristel Leung (U of T: University of Toronto)H-Index: 4
#2Parul Tandon (U of T: University of Toronto)H-Index: 12
Last. Vivian W. Huang (U of T: University of Toronto)H-Index: 12
view all 5 authors...
BACKGROUND Patients with inflammatory bowel disease (IBD) may be at increased risk of adverse neonatal outcomes. The aim of this study was to determine pooled incidences and risk factors for these outcomes. METHODS Medline, Embase, and Cochrane Library were searched through May 2019 for studies reporting adverse neonatal outcomes in IBD. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated. RESULTS The pooled incidence of preterm birth, low birth weight, congenital anomalies, an...
7 CitationsSource